Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Chengchao Xu¹, Yin Kwan Wong², Fu Long Liao³, Tingliang Jiang³, Jigang Wang⁴, Youyou Tu³

Affiliations

¹ Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
² Shenzhen People's Hospital, Shenzhen, China.
³ Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
⁴ Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China. Electronic address: jgwang@icmm.ac.cn.

PMID: 35460649
DOI: 10.1016/S1473-3099(22)00208-0

Comment

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Chengchao Xu et al. Lancet Infect Dis. 2022 May.

. 2022 May;22(5):585-586.

doi: 10.1016/S1473-3099(22)00208-0.

Authors

Chengchao Xu¹, Yin Kwan Wong², Fu Long Liao³, Tingliang Jiang³, Jigang Wang⁴, Youyou Tu³

Affiliations

¹ Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
² Shenzhen People's Hospital, Shenzhen, China.
³ Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China.
⁴ Shenzhen People's Hospital, Shenzhen, China; Artemisinin Research Centre and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100070, China. Electronic address: jgwang@icmm.ac.cn.

PMID: 35460649
DOI: 10.1016/S1473-3099(22)00208-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
van der Pluijm RW, Peto TJ, Hamaluba M, Callery JJ, Tripura R, White NJ, Dondorp AM. van der Pluijm RW, et al. Lancet Infect Dis. 2022 Jun;22(6):765-766. doi: 10.1016/S1473-3099(22)00283-3. Lancet Infect Dis. 2022. PMID: 35643100 Free PMC article. No abstract available.

Comment on

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
Hamaluba M, van der Pluijm RW, Weya J, Njuguna P, Ngama M, Kalume P, Mwambingu G, Ngetsa C, Wambua J, Boga M, Mturi N, Lal AA, Khuroo A, Taylor WRJ, Gonçalves S, Miotto O, Dhorda M, Mutinda B, Mukaka M, Waithira N, Hoglund RM, Imwong M, Tarning J, Day NPJ, White NJ, Bejon P, Dondorp AM. Hamaluba M, et al. Lancet Infect Dis. 2021 Oct;21(10):1395-1406. doi: 10.1016/S1473-3099(20)30929-4. Epub 2021 Jun 7. Lancet Infect Dis. 2021. PMID: 34111412 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Affiliations

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical